Cabaletta Bio to Present Rese-Cel Data at ASGCT 2026 Meeting
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) will present clinical, translational and manufacturing data on its investigational CAR T therapy rese-cel at the American Society of Gene & Cell …
Cabaletta Bio to Present Rese-Cel Data at ASGCT 2026 Meeting Read More